LobbyingClearmind Medicine lobbying by quarter
Clearmind Medicine CMND's latest lobbying report covers Q2 2026, at $20K. The four quarters Q4 2025–Q3 2026 total $40K. Its first report covers Q2 2025; the issues it reports most are Alcohol & Drug Abuse and Defense.
Clearmind MedicineCMND
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $40K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q2 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2025 | $10K | 1 |
| Q3 2025 | $10K | 1 |
| Q4 2025 | $10K | 1 |
| Q1 2026 | $10K | 1 |
| Q2 2026 | $20K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Alcohol and drug abuse$15K · 5 reports
- Defense$15K · 5 reports
- Health issues$15K · 5 reports
- Veterans$15K · 5 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Health & Human Services, Dept of (HHS)5 reports
- HOUSE OF REPRESENTATIVES5 reports
- SENATE5 reports
Firms it paid
| Firm | ||
|---|---|---|
| RK Strategies | $60K | 5 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/18for Q2 | RK Strategies | $20K |
| 04/20for Q1 | RK Strategies | $10K |
| 01/20for Q4 2025 | RK Strategies | $10K |
| 25/10/20for Q3 2025 | RK Strategies | $10K |
| 25/07/21for Q2 2025 | RK Strategies | $10K |
| 25/07/16for Q2 2025 | RK Strategies | Under $5,000 |